Jens Hoffmann, Germany

Jens Hoffmann , Ph.D.

Education and Research Experience

1989 Diploma in Pharmacy, Experimental Pharmacology and Toxicology

1989 - 1990 Central Institute for Cancer Research Berlin Clinical Pharmacology 

1991- 1994 German Cancer Research   Ph. D. Student 
Centre Heidelberg and Experimental Oncology
Max-Delbrück-Centrum for
Molecular Medicine Berlin 

1995 Schering AG Berlin Postdoctoral Training

1996 University of Pittsburgh Postdoctoral Training 
School of Medicine
Department of Pharmacology

1997 - 2009 Schering AG Berlin Group leader in Oncology Research
Bayer Pharma AG

2009 - EPO-Berlin Buch GmbH CEO
CRO services in preclinical oncology and translational research. 

Dr. Hoffmann has special expertise for pharmacological investigations concerning endocrine tumors. Biomarker and translational research is another focus of his scientific work. He has published more than 50 original articles in peer reviewed journals and filed more than 30 patents. Dr. Hoffmann is member of the German Cancer Foundation and the Board of the Experimental Cancer Research Division (AEK) and the American Association for Cancer Research (AACR).